Sharda Cropchem Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
805.80 -11.45 (-1.40%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
799.7
Today’s High
820.7
52 Week Low
318
52 Week High
832.35
804.05 -12.60 (-1.54%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
800
Today’s High
820.8
52 Week Low
318.05
52 Week High
832.75
Key Metrics
- Market Cap (In Cr) 7367.86
- Beta 1.16
- Div. Yield (%) 0.37
- P/B 3.29
- TTM P/E 23.44
- Peg Ratio -0.7
- Sector P/E 24.11
- D/E 0.01
- Open Price 804.65
- Prev Close 817.25
Sharda Cropchem Analysis
Price Analysis
-
1 Week2.99%
-
3 Months46.27%
-
6 Month96.62%
-
YTD80.36%
-
1 Year94.88%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 2
- 2
- 2
- 2
- Hold
- 2
- 2
- 2
- 2
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 5
- 5
- 5
- 5
Sharda Cropchem News
Pranik Logistics, Semac Consultants & others hit 52 week low today ;Check the full list here?
4 min read . 31 Oct 2024Prudent Corporate Advisory Services, Wockhardt & others hit 52 week high today ; Do you own any?
4 min read . 31 Oct 2024Spandana Sphoorty Financial, Indusind Bank & others hit 52 week low today ;Check the full list here?
3 min read . 29 Oct 2024Gillette India, Sharda Cropchem & others hit 52 week high today ; Do you own any?
3 min read . 29 Oct 2024Sharda Cropchem Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3163.02
- Selling/ General/ Admin Expenses Total
- 42.43
- Depreciation/ Amortization
- 267.13
- Other Operating Expenses Total
- 495.34
- Total Operating Expense
- 3147.3
- Operating Income
- 15.73
- Net Income Before Taxes
- 71.87
- Net Income
- 31.88
- Diluted Normalized EPS
- 3.53
- Period
- 2024
- Total Assets
- 4038.32
- Total Liabilities
- 1801.21
- Total Equity
- 2237.12
- Tangible Book Valueper Share Common Eq
- 140.13
- Period
- 2024
- Cashfrom Operating Activities
- 341.3
- Cashfrom Investing Activities
- -393.49
- Cashfrom Financing Activities
- -36.91
- Net Changein Cash
- -89.02
- Period
- 2023
- Total Revenue
- 4045.16
- Selling/ General/ Admin Expenses Total
- 375.56
- Depreciation/ Amortization
- 248.12
- Other Operating Expenses Total
- 0.7
- Total Operating Expense
- 3578.74
- Operating Income
- 466.42
- Net Income Before Taxes
- 430.74
- Net Income
- 341.96
- Diluted Normalized EPS
- 38.95
- Period
- 2023
- Total Assets
- 4350.83
- Total Liabilities
- 2118.81
- Total Equity
- 2232.02
- Tangible Book Valueper Share Common Eq
- 151.31
- Period
- 2023
- Cashfrom Operating Activities
- 328.28
- Cashfrom Investing Activities
- -145.16
- Cashfrom Financing Activities
- -97.1
- Net Changein Cash
- 119.67
- Period
- 2022
- Total Revenue
- 3579.77
- Selling/ General/ Admin Expenses Total
- 297.02
- Depreciation/ Amortization
- 245.33
- Other Operating Expenses Total
- 1.13
- Total Operating Expense
- 3125.62
- Operating Income
- 454.15
- Net Income Before Taxes
- 464.24
- Net Income
- 349.25
- Diluted Normalized EPS
- 41.18
- Period
- 2022
- Total Assets
- 3743.13
- Total Liabilities
- 1830.67
- Total Equity
- 1912.46
- Tangible Book Valueper Share Common Eq
- 124.46
- Period
- 2022
- Cashfrom Operating Activities
- 267.1
- Cashfrom Investing Activities
- -207.89
- Cashfrom Financing Activities
- -90.96
- Net Changein Cash
- -28.86
- Period
- 2021
- Total Revenue
- 2395.61
- Selling/ General/ Admin Expenses Total
- 264.11
- Depreciation/ Amortization
- 170.44
- Other Operating Expenses Total
- 1.07
- Total Operating Expense
- 2149.2
- Operating Income
- 246.41
- Net Income Before Taxes
- 309.45
- Net Income
- 229.17
- Diluted Normalized EPS
- 28.55
- Period
- 2021
- Total Assets
- 2863.86
- Total Liabilities
- 1249.56
- Total Equity
- 1614.3
- Tangible Book Valueper Share Common Eq
- 106.38
- Period
- 2021
- Cashfrom Operating Activities
- 246.37
- Cashfrom Investing Activities
- -281.58
- Cashfrom Financing Activities
- 43.35
- Net Changein Cash
- 7.79
- Period
- 2020
- Total Revenue
- 2003.02
- Selling/ General/ Admin Expenses Total
- 233.5
- Depreciation/ Amortization
- 137.12
- Other Operating Expenses Total
- 0.89
- Total Operating Expense
- 1843.13
- Operating Income
- 159.89
- Net Income Before Taxes
- 184.87
- Net Income
- 164.66
- Diluted Normalized EPS
- 23.65
- Period
- 2020
- Total Assets
- 2347.22
- Total Liabilities
- 944.43
- Total Equity
- 1402.79
- Tangible Book Valueper Share Common Eq
- 94.53
- Period
- 2020
- Cashfrom Operating Activities
- 146.3
- Cashfrom Investing Activities
- -67.76
- Cashfrom Financing Activities
- -59.7
- Net Changein Cash
- 27.12
- Period
- 2019
- Total Revenue
- 2001.14
- Selling/ General/ Admin Expenses Total
- 214.8
- Depreciation/ Amortization
- 99.39
- Other Operating Expenses Total
- 0.82
- Total Operating Expense
- 1728.95
- Operating Income
- 272.2
- Net Income Before Taxes
- 235.02
- Net Income
- 176.34
- Diluted Normalized EPS
- 23.06
- Period
- 2019
- Total Assets
- 2203.35
- Total Liabilities
- 919.44
- Total Equity
- 1283.91
- Tangible Book Valueper Share Common Eq
- 78.24
- Period
- 2019
- Cashfrom Operating Activities
- 556.31
- Cashfrom Investing Activities
- -359.83
- Cashfrom Financing Activities
- -215.54
- Net Changein Cash
- -10.58
- Period
- 2024-09-30
- Total Revenue
- 776.89
- Selling/ General/ Admin Expenses Total
- 10.37
- Depreciation/ Amortization
- 69.1
- Other Operating Expenses Total
- 114.69
- Total Operating Expense
- 756.37
- Operating Income
- 20.52
- Net Income Before Taxes
- 45.52
- Net Income
- 42.41
- Diluted Normalized EPS
- 4.7
- Period
- 2024-09-30
- Total Assets
- 3831.95
- Total Liabilities
- 1538.19
- Total Equity
- 2293.76
- Tangible Book Valueper Share Common Eq
- 146.82
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 457.76
- Cashfrom Investing Activities
- -329.27
- Cashfrom Financing Activities
- -34.51
- Net Changein Cash
- 108.73
- Period
- 2024-06-30
- Total Revenue
- 785.11
- Selling/ General/ Admin Expenses Total
- 11.15
- Depreciation/ Amortization
- 64.78
- Other Operating Expenses Total
- 140.68
- Total Operating Expense
- 772.85
- Operating Income
- 12.26
- Net Income Before Taxes
- 30.79
- Net Income
- 27.25
- Diluted Normalized EPS
- 3.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1312.05
- Selling/ General/ Admin Expenses Total
- 14.71
- Depreciation/ Amortization
- 54.26
- Other Operating Expenses Total
- 169.03
- Total Operating Expense
- 1096.26
- Operating Income
- 215.8
- Net Income Before Taxes
- 198.41
- Net Income
- 143.47
- Diluted Normalized EPS
- 15.82
- Period
- 2024-03-31
- Total Assets
- 4038.32
- Total Liabilities
- 1801.21
- Total Equity
- 2237.12
- Tangible Book Valueper Share Common Eq
- 140.13
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 341.3
- Cashfrom Investing Activities
- -393.49
- Cashfrom Financing Activities
- -36.91
- Net Changein Cash
- -89.02
- Period
- 2023-12-31
- Total Revenue
- 632.46
- Selling/ General/ Admin Expenses Total
- 9.36
- Depreciation/ Amortization
- 68.63
- Other Operating Expenses Total
- 110.21
- Total Operating Expense
- 655.05
- Operating Income
- -22.58
- Net Income Before Taxes
- 12.12
- Net Income
- 4.64
- Diluted Normalized EPS
- 0.51
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 580.76
- Selling/ General/ Admin Expenses Total
- 9.2
- Depreciation/ Amortization
- 73.97
- Other Operating Expenses Total
- 101.42
- Total Operating Expense
- 619.83
- Operating Income
- -39.07
- Net Income Before Taxes
- -33.83
- Net Income
- -27.58
- Diluted Normalized EPS
- -3.06
- Period
- 2023-09-30
- Total Assets
- 3337.42
- Total Liabilities
- 1248.76
- Total Equity
- 2088.66
- Tangible Book Valueper Share Common Eq
- 129.53
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 169.77
- Cashfrom Investing Activities
- -146.8
- Cashfrom Financing Activities
- -36.88
- Net Changein Cash
- -14.65
- Period
- 2023-06-30
- Total Revenue
- 637.75
- Selling/ General/ Admin Expenses Total
- 9.16
- Depreciation/ Amortization
- 70.28
- Other Operating Expenses Total
- 115.31
- Total Operating Expense
- 776.8
- Operating Income
- -139.05
- Net Income Before Taxes
- -104.82
- Net Income
- -88.64
- Diluted Normalized EPS
- -9.82
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1481.82
- Selling/ General/ Admin Expenses Total
- 15.16
- Depreciation/ Amortization
- 67.66
- Other Operating Expenses Total
- 146.37
- Total Operating Expense
- 1243.11
- Operating Income
- 238.71
- Net Income Before Taxes
- 255.14
- Net Income
- 198.83
- Diluted Normalized EPS
- 22.05
- Period
- 2023-03-31
- Total Assets
- 4350.83
- Total Liabilities
- 2118.81
- Total Equity
- 2232.02
- Tangible Book Valueper Share Common Eq
- 151.31
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 328.28
- Cashfrom Investing Activities
- -145.16
- Cashfrom Financing Activities
- -97.1
- Net Changein Cash
- 119.67
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Sharda Cropchem Technical
Moving Average
SMA
- 5 Day790.82
- 10 Day796.19
- 20 Day732.92
- 50 Day634.8
- 100 Day584.3
- 300 Day480.23
Sharda Cropchem Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Anupam Rasayan India
- 725.2
- -6.25
- -0.85
- 1107.45
- 672.75
- 7961.68
- Gujarat State Fertilizers & Chemicals
- 190.6
- -3.05
- -1.58
- 322.45
- 179.15
- 7594.98
- Sharda Cropchem
- 805.8
- -11.45
- -1.4
- 832.35
- 318
- 7269.97
- Indigo Paints
- 1500
- -0.6
- -0.04
- 1720
- 1253.15
- 7143.15
- Privi Speciality Chemicals
- 1766.55
- -22.7
- -1.27
- 2030
- 975
- 6900.62
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Anupam Rasayan India
- 63.5
- 2.91
- 7.4
- 12.03
- Gujarat State Fertilizers & Chemicals
- 13.69
- 0.61
- 6.58
- 7.3
- Sharda Cropchem
- 155.57
- 3.29
- 12.52
- 7.36
- Indigo Paints
- 48.79
- 7.92
- 17.78
- 10.43
- Privi Speciality Chemicals
- 74.75
- 7.56
- 12.81
- 6.48
Sharda Cropchem Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 25-Oct-24
- Quarterly Results
- 23-Jul-24
- Quarterly Results
- 10-May-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 21-Oct-23
- Quarterly Results
- 24-Jul-23
- Quarterly Results
- 12-May-23
- Audited Results & Final Dividend
- 24-Jan-23
- Quarterly Results & Interim Dividend
- 21-Oct-22
- Quarterly Results
- 25-Jul-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-Aug-24
- 03-Jul-24
- AGM
- 17-Jan-24
- 12-Dec-23
- POM
- 02-Aug-23
- 21-Jun-23
- AGM
- 02-Aug-22
- 28-Jun-22
- AGM
- 29-Jul-21
- 29-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 10-May-24
- 02-Aug-24
- 02-Aug-24
- 3
- 12-May-23
- 01-Aug-23
- 01-Aug-23
- 3
- 24-Jan-23
- 07-Feb-23
- 07-Feb-23
- 3
- 13-May-22
- 26-Jul-22
- 25-Jul-22
- 3
- 24-Jan-22
- 03-Feb-22
- 02-Feb-22
- 3
- 26-May-21
- 22-Jul-21
- 20-Jul-21
- 3